ANDA 210928, held by Aurobindo Pharma USA. Azelaic Acid.
As of Nov 15, 2026, ANDA 210928 (Azelaic Acid), held by Aurobindo Pharma USA, was first approved by FDA on Oct 7, 2020, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 7, 2020 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Azelaic Acid15% ยท aerosol, foam;topical | Azelaic Acid | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
